Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.
Paterson, Catherine; Kennedy, Catriona
Professor Catriona Kennedy email@example.com
Queens Nursing Inst Scotland - Professor
Prostatitis is a common condition which can affect men of all ages; however, it is more frequently experienced in younger men with an initial onset around 40 years of age. The two main presenting clinical features of prostatitis are lower urinary tract symptoms and pelvic pain. Other symptoms might include obstructive or irritative voiding symptoms, ejaculatory pain, and hematospermia. A diagnosis is usually based on the man's history, physical examination, urinalysis, and the two-or four-glass test (also known as obtaining urine specimens before, during, and after prostatic massage). Further investigations may also be performed when considering the differential diagnosis. Prostatitis can result in a significant reduction in quality of life (QOL) and pain can be associated with sexual dysfunction in men. Prostatitis can be classified as four distinct types, namely, type I acute prostatitis, type II chronic bacterial prostatitis, type III chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), and type IV asymptomatic prostatitis. It is unclear whether type III can be linked in all cases to prostatic involvement therefore the alternate denomination CPPS is used in clinical practice. Furthermore, CP/CPPS is further subclassified as type IIIa (inflammatory), and type IIIb (noninflammatory) which is dependent on the presence of inflammatory cells in prostatic secretions. CP/CPPS is considered when pelvic pain is present for at least three of the preceding 6 months with no other identifiable causes determined. There are several hypothesized causes of CP/CPPS which include: neuropsychological factors, infection, inflammation/autoimmunity, and dyssynergia voiding associated with bladder neck hypertrophy. Given the wide range of potential causes of CP/CPPS, there are many pharmacological interventions available in clinical practice to manage this complex condition. It is important to critically summarize evidence-based recommendations to inform the clinical management of men affected by CP/CPPS (Franco et al., 2019).
|Journal Article Type||Review|
|Journal||Research in nursing and health|
|Publisher||Wiley Open Access|
|Peer Reviewed||Peer Reviewed|
|Item Discussed||FRANCO, J.V.A., TURK, T., JUNG, J.H., XIAO, Y.-T., IAKHNO, S. TIRAPEGUI, F.I., GARROTE, V. and VIETTO, V. 2019. Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Cochrane database of systematic reviews, 10, artic|
|Institution Citation||PATERSON, C. and KENNEDY, C. . Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Research in nursing and health [online], Early View. Available from: https://doi.org/10.1002/nur.22027|
|Keywords||Prostatitis; Men; Lower urinary tract; Pelvic pain; Pharmacological therapies; Sexual dysfunction; Quality of life; Depression|
This file is under embargo until May 21, 2021 due to copyright reasons.
Contact firstname.lastname@example.org to request a copy for personal use.
You might also like
Community nurses and the ‘new normal’
Using aquablation to treat lower urinary tract symptoms in benign prostatic hyperplasia.
Systematic and integrative reviews: synthesising evidence for community nursing practice.